Figure 6.
Figure 6. Kinetics of increased surface marker expression on T cells and CD8+ DCs after TLI in wild-type and Batf3−/− mice. (A) Representative FACS patterns of PD-1 on gated CD4+CD25− conventional T cells (Tcon), or PD-1 on gated CD8+ T cells, or PD-1 on gated CD4+CD25+ Tregs from untreated (n = 8) or TLI-treated wild-type mice (n = 11). (B) Similar stainings are shown in untreated (n = 5) or TLI-treated Batf3−/− mice (n = 10). (C-E) Percentages of PD-1+ cells among T-cell subsets from untreated WT or Batf3−/− mice or from TLI-treated WT or Batf3−/− mice. (F) Percentages of gated splenic CD8+ DCs that expressed Tim-4, DEC205, Treml4, or SIRPα before, during, or after 10 daily doses of TLI conditioning. (G) Percentages of gated NKT, Tregs, conventional CD4+ and conventional CD8+ T cells that expressed PD-1 or NKG2D at the different time points shown in panel F.

Kinetics of increased surface marker expression on T cells and CD8+ DCs after TLI in wild-type and Batf3−/−mice. (A) Representative FACS patterns of PD-1 on gated CD4+CD25 conventional T cells (Tcon), or PD-1 on gated CD8+ T cells, or PD-1 on gated CD4+CD25+ Tregs from untreated (n = 8) or TLI-treated wild-type mice (n = 11). (B) Similar stainings are shown in untreated (n = 5) or TLI-treated Batf3−/− mice (n = 10). (C-E) Percentages of PD-1+ cells among T-cell subsets from untreated WT or Batf3−/− mice or from TLI-treated WT or Batf3−/− mice. (F) Percentages of gated splenic CD8+ DCs that expressed Tim-4, DEC205, Treml4, or SIRPα before, during, or after 10 daily doses of TLI conditioning. (G) Percentages of gated NKT, Tregs, conventional CD4+ and conventional CD8+ T cells that expressed PD-1 or NKG2D at the different time points shown in panel F.

Close Modal

or Create an Account

Close Modal
Close Modal